Jon Edwards - Profile and Investment Details

Investor Profile

Jon Edwards is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Rondo Therapeutics, Spolia Therapeutics, Inc., Gadeta, SynOx Therapeutics, SuperX, Palladio Biosciences, Inc., Critical PressureExcellergy Related to search terms in your query, Impact Biomedicines, Inexia, Aura Biosciences, Janpix, Alderaan Biotechnology, Index Ventures, CatalYm GmbH, Altesa BioSciences, Inc., ApcinteX, Z FACTOR LIMITED, Sardona Therapeutics, Yukin Therapeutics, Xenikos, Palladio Biosciences, Mavalon Therapeutics, Kymo Therapeutics, Sydnexis, Z Factor, Stealthyx Therapeutics, Checkmate Pharmaceuticals, Red Tree Venture Capital, Orexia, Vaxcyte, Morphogen-IX, ULTRAHUMAN LIMITED, Phathom Pharmaceuticals, Diasome Pharmaceuticals, Capella BioScience, Synthorx Inc, RXCELERATE LIMITED, AIRNA, Divide and Conquer, Synthorx, Impact Biomedicines, Inc., Bicara Therapeutics, Breakpoint Therapeutics, . Over time, Jon Edwards has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jon Edwards is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Hospitals, Autoimmune Diseases, Wellness, Women Founded, Immunotherapy, Rare Diseases, Investment Management, Energy, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Finance, Bioinformatics, Biotechnology, Medical Devices, Drug Development, Hispanic / Latinx Founded, Clean Technology, Electronic Health Records (EHR), Health and Hospital Services, Precision Medicine, Environmental Technology, Neuropsychiatric Disorders, Clinical Trials, FinTech, Capital Raising, Gene Therapy, Logistics, Regulatory Compliance, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Cellular Therapy, App Discovery, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Jon Edwards, as their portfolio suggests a familiarity and interest in this area.

Understanding Jon Edwards’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.